Cover Image

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV

Background: In low- and middle-income countries (LMICs), a substantial unmet need for affordable single-tablet regimen (STR) options remains. Rilpivirine (RPV, TMC278) is formulated in a low-cost STR with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC). Objectives: Switching at Low HIV-1...

Full description

Saved in:
Bibliographic Details
Main Authors: Paula Munderi (Author), Edwin Were (Author), Anchalee Avihingsanon (Author), Pascale A.M Mbida (Author), Lerato Mohapi (Author), Samba B. Moussa (Author), Marjolein Jansen (Author), Ceyhun Bicer (Author), Perry Mohammed (Author), Yvon van Delft (Author)
Format: Book
Published: AOSIS, 2019-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items